LOC105372881: A Promising Drug Target and Biomarker (G105372881)
LOC105372881: A Promising Drug Target and Biomarker
Introduction
LOC105372881 is a novel gene that has recently been identified as a potential drug target and biomarker. This gene is located on chromosome 6p21.3 and encodes a protein known as LOC105372881. LOC105372881 functions as a key regulator of cell adhesion and plays a crucial role in the development and maintenance of tissues. The identification of LOC105372881 as a potential drug target has significant implications for the development of new therapeutic approaches for various diseases.
Drug Target and Biomarker Characterization
LOC105372881 is a highly conserved gene that is expressed in almost all eukaryotic cells. It is localized to the nucleus and has been shown to play a role in various cellular processes, including cell adhesion, migration, and invasion. LOC105372881 is also known to be involved in the regulation of cell cycle progression and has been implicated in the development and progression of various diseases, including cancer.
Recent studies have demonstrated that LOC105372881 can be a potential drug target for several diseases, including cancer. Several studies have shown that LOC105372881 is highly expressed in various cancer types, including breast, lung, and ovarian cancer. Additionally, LOC105372881 has been shown to play a role in the regulation of cell adhesion and angiogenesis, which are critical processes in the development of cancer.
LOC105372881 is also a potential biomarker for several diseases, including cancer. The expression of LOC105372881 has been shown to be associated with the development and progression of various diseases, including cancer. Additionally, LOC105372881 has been shown to have potential as a diagnostic biomarker for cancer , as its expression has been shown to be altered in various cancer types.
Importance of LOC105372881 as a Drug Target
The identification of LOC105372881 as a potential drug target has significant implications for the development of new therapeutic approaches for various diseases. LOC105372881 has been shown to play a key role in the regulation of cell adhesion and angiogenesis, which are critical processes in the development and progression of many diseases, including cancer.
The potential drug target status of LOC105372881 also makes it an attractive target for small molecules, which are often effective in inhibiting the activity of protein tyrosine kinases. Small molecules have the advantage of being able to selectively target specific proteins and have a lower risk of toxicity compared to traditional anti-cancer drugs.
LOC105372881 has also been shown to play a role in the regulation of cell cycle progression, which is a critical process in the development and progression of cancer. The inhibition of LOC105372881 function has been shown to have potential in treating cancer by inhibiting cell proliferation and preventing the formation of new blood vessels that feed the tumor.
Conclusion
LOC105372881 is a novel gene that has recently been identified as a potential drug target and biomarker. Its conservation and involvement in various cellular processes make it an attractive target for small molecules. The identification of LOC105372881 as a potential drug target and biomarker has significant implications for the development of new therapeutic approaches for various diseases. Further studies are needed to fully understand the function and potential of LOC105372881 and its role in the development and progression of diseases.
Protein Name: Uncharacterized LOC105372881
The "LOC105372881 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105372881 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC105372900 | LOC105372912 | LOC105372932 | LOC105372948 | LOC105372969 | LOC105372976 | LOC105372985 | LOC105372988 | LOC105372990 | LOC105372997 | LOC105373000 | LOC105373002 | LOC105373024 | LOC105373027 | LOC105373033 | LOC105373038 | LOC105373053 | LOC105373100 | LOC105373146 | LOC105373170 | LOC105373220 | LOC105373227 | LOC105373230 | LOC105373231 | LOC105373234 | LOC105373238 | LOC105373304 | LOC105373313 | LOC105373336 | LOC105373353 | LOC105373383 | LOC105373389 | LOC105373399 | LOC105373405 | LOC105373413 | LOC105373422 | LOC105373426 | LOC105373439 | LOC105373445 | LOC105373456 | LOC105373465 | LOC105373485 | LOC105373556 | LOC105373567 | LOC105373585 | LOC105373605 | LOC105373608 | LOC105373611 | LOC105373623 | LOC105373629 | LOC105373649 | LOC105373652 | LOC105373657 | LOC105373659 | LOC105373660 | LOC105373677 | LOC105373696 | LOC105373703 | LOC105373707 | LOC105373710 | LOC105373712 | LOC105373717 | LOC105373723 | LOC105373730 | LOC105373750 | LOC105373751 | LOC105373759 | LOC105373781 | LOC105373796 | LOC105373831 | LOC105373835 | LOC105373836 | LOC105373874 | LOC105373882 | LOC105373891 | LOC105373918 | LOC105373920 | LOC105373937 | LOC105374007 | LOC105374009 | LOC105374020 | LOC105374025 | LOC105374033 | LOC105374036 | LOC105374037 | LOC105374041 | LOC105374060 | LOC105374089 | LOC105374107 | LOC105374140 | LOC105374174 | LOC105374187 | LOC105374193 | LOC105374207 | LOC105374210 | LOC105374211 | LOC105374217 | LOC105374218 | LOC105374224 | LOC105374226
